NL189255C - 2,4-dichloor-alfa-(n-imidazolylmethyl)-dibenzyletherderivaat, alsmede een deze verbinding omvattend farmaceutisch preparaat. - Google Patents

2,4-dichloor-alfa-(n-imidazolylmethyl)-dibenzyletherderivaat, alsmede een deze verbinding omvattend farmaceutisch preparaat.

Info

Publication number
NL189255C
NL189255C NLAANVRAGE7903872,A NL7903872A NL189255C NL 189255 C NL189255 C NL 189255C NL 7903872 A NL7903872 A NL 7903872A NL 189255 C NL189255 C NL 189255C
Authority
NL
Netherlands
Prior art keywords
dichlorous
imidazolylmethyl
alfa
compound
pharmaceutical composition
Prior art date
Application number
NLAANVRAGE7903872,A
Other languages
English (en)
Dutch (nl)
Other versions
NL7903872A (nl
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of NL7903872A publication Critical patent/NL7903872A/xx
Application granted granted Critical
Publication of NL189255C publication Critical patent/NL189255C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
NLAANVRAGE7903872,A 1978-05-18 1979-05-16 2,4-dichloor-alfa-(n-imidazolylmethyl)-dibenzyletherderivaat, alsmede een deze verbinding omvattend farmaceutisch preparaat. NL189255C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23546/78A IT1096361B (it) 1978-05-18 1978-05-18 Dibenzileteri sostituiti terapeuticamente attivi

Publications (2)

Publication Number Publication Date
NL7903872A NL7903872A (nl) 1979-11-20
NL189255C true NL189255C (nl) 1993-02-16

Family

ID=11208025

Family Applications (2)

Application Number Title Priority Date Filing Date
NLAANVRAGE7903872,A NL189255C (nl) 1978-05-18 1979-05-16 2,4-dichloor-alfa-(n-imidazolylmethyl)-dibenzyletherderivaat, alsmede een deze verbinding omvattend farmaceutisch preparaat.
NL930014C NL930014I2 (nl) 1978-05-18 1993-02-19 2,4-Dichloor-alpha(N-imidazolylmethyl)-dibenzyletherderivaat, alsmede een deze verbinding omvattend farmaceutisch preparaat.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL930014C NL930014I2 (nl) 1978-05-18 1993-02-19 2,4-Dichloor-alpha(N-imidazolylmethyl)-dibenzyletherderivaat, alsmede een deze verbinding omvattend farmaceutisch preparaat.

Country Status (29)

Country Link
JP (1) JPS605592B2 (fr)
AR (1) AR219596A1 (fr)
AT (1) AT372950B (fr)
AU (1) AU523053B2 (fr)
CA (1) CA1115718A (fr)
CH (1) CH639075A5 (fr)
DD (1) DD143608A5 (fr)
DE (1) DE2917244C2 (fr)
DK (1) DK153838C (fr)
EG (1) EG14345A (fr)
ES (1) ES480552A1 (fr)
FI (1) FI71309C (fr)
FR (1) FR2426047A1 (fr)
GB (1) GB2025395B (fr)
GR (1) GR68396B (fr)
HU (1) HU182565B (fr)
IE (1) IE48372B1 (fr)
IL (1) IL57245A (fr)
IT (1) IT1096361B (fr)
MX (1) MX5927E (fr)
NL (2) NL189255C (fr)
NO (1) NO152840C (fr)
NZ (1) NZ190412A (fr)
PH (1) PH14782A (fr)
PT (1) PT69537A (fr)
SE (1) SE444812B (fr)
SU (1) SU816399A3 (fr)
YU (1) YU112279A (fr)
ZA (1) ZA792015B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1155853A (fr) * 1980-06-06 1983-10-25 Joseph A. Martin Derives d'imidazole, et leur preparation
FR2541114B1 (fr) * 1983-02-23 1986-04-11 Sanofi Sa Compositions pharmaceutiques antifongiques utilisables par voie orale contenant de l'omoconazole
DK79184A (da) * 1983-02-23 1984-08-24 Sanofi Sa Fungicide farmaceutiske midler indeholdende et imidazolderivat
CA1250586A (fr) * 1984-02-02 1989-02-28 Manuel Raga Derives de 1h-imidazole et procede de production
DE3413365A1 (de) * 1984-04-09 1985-12-19 Merz + Co GmbH & Co, 6000 Frankfurt Substituierte phenylethylderivate, verfahren zu ihrer herstellung und pharmazeutische mittel
IT1200422B (it) * 1985-03-19 1989-01-18 Ripari Gero Ist Farm Biolog Composto con attivita' antimicrobia,sua preparazione e composizioni farmaceutiche che lo contengono
ES2249992B1 (es) * 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Un procedimiento para fabricar compuestos enantiomericos del imidazol.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
GB1475271A (en) * 1975-04-30 1977-06-01 Pfizer Ltd 1-aryl-2-1-imidazolyl-alkyl ethers and thioethers and their use as antifungal agents

Also Published As

Publication number Publication date
MX5927E (es) 1984-08-29
DE2917244C2 (de) 1985-09-05
SE444812B (sv) 1986-05-12
IL57245A (en) 1983-02-23
SU816399A3 (ru) 1981-03-23
YU112279A (en) 1983-01-21
IL57245A0 (en) 1979-09-30
IT1096361B (it) 1985-08-26
IE790958L (en) 1979-11-18
ES480552A1 (es) 1980-04-01
FR2426047B1 (fr) 1982-11-05
AT372950B (de) 1983-11-25
JPS54151974A (en) 1979-11-29
GR68396B (fr) 1981-12-29
FI791543A (fi) 1979-11-19
ZA792015B (en) 1980-04-30
HU182565B (en) 1984-02-28
NZ190412A (en) 1981-03-16
NO791599L (no) 1979-11-20
JPS605592B2 (ja) 1985-02-12
FR2426047A1 (fr) 1979-12-14
FI71309B (fi) 1986-09-09
GB2025395A (en) 1980-01-23
PH14782A (en) 1981-12-09
DK153838B (da) 1988-09-12
FI71309C (fi) 1986-12-19
NL930014I1 (nl) 1993-05-03
GB2025395B (en) 1982-07-28
AR219596A1 (es) 1980-08-29
ATA345079A (de) 1983-04-15
DD143608A5 (de) 1980-09-03
IT7823546A0 (it) 1978-05-18
PT69537A (fr) 1979-05-01
IE48372B1 (en) 1984-12-26
NL930014I2 (nl) 1993-09-16
EG14345A (en) 1983-09-30
CH639075A5 (fr) 1983-10-31
DK153838C (da) 1989-01-30
DK196579A (da) 1979-11-19
NO152840C (no) 1985-11-27
SE7904319L (sv) 1979-11-19
NO152840B (no) 1985-08-19
NL7903872A (nl) 1979-11-20
CA1115718A (fr) 1982-01-05
DE2917244A1 (de) 1979-11-22
AU4714979A (en) 1979-11-22
AU523053B2 (en) 1982-07-08

Similar Documents

Publication Publication Date Title
NL180227C (nl) Aerosolsamenstelling.
NL7901842A (nl) Beademingsapparaat.
NL193457B (nl) Benzoheterocyclische verbindingen en farmaceutisch preparaat dat een dergelijke verbinding bevat.
NL191540C (nl) Verbinding met antihypercholesteremische werkzaamheid, alsmede farmaceutisch preparaat dat deze verbinding bevat.
NL184309C (nl) Beademingstoestel.
IT8020085A0 (it) Perfezionamenti relativi a tenute.
NO153847C (no) 2,4,4-triklor-4-formyl-butyronitril.
IT7928432A0 (it) Composizione cromogena.
IT7926662A0 (it) Composizione farmaceutica contenente 3,4-di-idro-3-osso-2-chinossaline.
ES491221A0 (es) Un procedimiento para preparar un compuesto de 1,8-naftiri- dina
DE2962423D1 (en) Solid stable pharmaceutical composition on the basis of a 1,3-diester of 17-alpha-ethynyl-7-alpha-methyl-1,3,5(10)-estratriene-1,3,17-beta-triol
NL191386C (nl) Een 16-hydroxy-prostaglandine verbinding.
NL189255C (nl) 2,4-dichloor-alfa-(n-imidazolylmethyl)-dibenzyletherderivaat, alsmede een deze verbinding omvattend farmaceutisch preparaat.
IT7926502A0 (it) Composto a base di2,6-diammino-nebularina.
MX3897E (es) Un procedimiento para la preparacion de composiciones insecticidas que contienen (6,7,8,9,10,10-hexacloro-1,5,5a,6,9,9a,-hexahidro-6,9-metano-2,4,3,-benzodioxatiepin-3-oxido)
IT7950715A0 (it) Composizioni farmaceutiche a basedi ariltrifluotoetanolo
IT8019430A0 (it) Formulazione farmaceutica a cessione protratta.
ATA457479A (de) Stabilisietes 1,1,1-trichloraethan
ATA457579A (de) Stabilisiertes 1,1,1-trichloraethan
ES491222A0 (es) Un procedimiento para preparar un compuesto de 1,8-naftiri- dina.
GB2026861B (en) Pharmaceutical compositions containing 5-methyl-7-diethylamino-s-triazolo (1,5- )-pyrimidine
IT8025835A0 (it) Ftalazinolo. composizione farmaceutica a base di
IT8221726A0 (it) Composizione insetticida.
IT1207193B (it) (1-alchil-5-nitro-2-imidazolil)-vinil-gliossale-diacetali, loro preparazione e composizioni farmaceutiche a base di detti composti.
IT7823795A0 (it) 1,2,4-triazolidin-3-oni e-tioni fungicidi.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
AC1 Application for a supplementary protection certificate

Free format text: 930014, 930219

KC1 Grant of a supplementary protection certificate

Free format text: 930014, 990516, EXPIRES:20001013

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 19990516